Presence of opioid growth factor and its receptor in the normal dog, cat and horse cornea

Veterinary Ophthalmology

Volumn 6, Issue 2, 2003, Pages 131-134

  Robertson, Sheilah A ^a   Andrew, Stacy E ^a  

^a University of Florida   (United States)

Author keywords

Cornea; Epithelium; Opioid; Wound healing

Indexed keywords

METENKEPHALIN; OPIATE RECEPTOR; METHIONINE ENKEPHALIN RECEPTOR; METHIONINE-ENKEPHALIN RECEPTOR;

ANIMAL TISSUE; ARTICLE; CAT; CONTROLLED STUDY; CORNEA EPITHELIUM; DOG; HORSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; ANIMAL; ANIMAL DISEASE; CORNEA; METABOLISM;

ANIMALIA; CANIS FAMILIARIS; EQUIDAE; EQUUS CABALLUS; FELIS CATUS; ORYCTOLAGUS CUNICULUS;

ANIMALS; CATS; CORNEA; DOGS; ENKEPHALIN, METHIONINE; HORSES; IMMUNOHISTOCHEMISTRY; RECEPTORS, OPIOID;

EID: 0037629989     PISSN: 14635216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-5224.2003.00279.x     Document Type: Article

References (25)

1. Zagon IS, Sassani JW, Allison G, McLaughlin PJ. Conserved expression of the opioid growth factor, [Met5]enkephalin, and the zeta opioid receptor in vertebrate cornea. Brain Research 1995; 671: 105-111.
2. Zagon IS, Sassani JW, McLaughlin PJ. Opioid growth factor modulates corneal epithelial outgrowth in tissue culture. American Journal of Physiology 1995; 268: R942-R950.
3. McLaughlin PJ, Wu Y. Identification and characterization of the zeta-opioid receptor in developing rat heart. American Journal of Physiology 1997; 272: R1841-R1846.
4. Wu Y, McLaughlin PJ, Zagon IS. Ontogeny of the opioid growth factor, [Met5]-enkephalin, preproenkephalin gene expression, and the zeta opioid receptor in the developing and adult aorta of rat. Developmental Dynamics 1998; 211: 327-337.
5. Zagon IS, Wu Y, McLaughlin PJ. Opioid growth factor and organ development in rat and human embryos. Brain Research 1999; 839: 313-322.
6. Zagon IS, Wu Y, McLaughlin PJ. The opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor are present in human and mouse skin and tonically act to inhibit DNA synthesis in the epidermis. Journal of Investigative Dermatology 1996; 106: 490-497.
7. Zagon IS, Wu Y, McLaughlin PJ. Opioid growth factor is present in human and mouse gastrointestinal tract and inhibits DNA synthesis. American Journal of Physiology 1997; 272: R1094-R1104.
8. Zagon IS, Gibo DM, McLaughlin PJ. Ontogeny of ξ (zeta), the opioid growth factor receptor, in the rat brain. Brain Research 1992; 596: 149-156.
9. Levin RJ, Wu Y, McLaughlin PJ, Zagon IS. Expression of the opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor in head and neck squamous cell carcinoma. Laryngoscope 1997; 107: 335-339.
10. Zagon IS, Roesener CD, Verderame MF et al. Opioid growth factor regulates the cell cycle of human neoplasias. International Journal of Oncology 2000; 17: 1053-1061.
11. Zagon IS, Sassani JW, McLaughlin PJ et al. Re-epithelialization of the rabbit cornea is regulated by opioid growth factor. Brain Research 1998; 803: 61-68.
12. Zagon IS, Sassani JW, McLaughlin PJ et al. Re-epithelialization of the human cornea is regulated by endogenous opioids. Investigative Ophthalmology and Visual Science 2000; 41: 73-81.
13. Zagon IS, Sassani JW, Kane ER et al. Homeostasis of ocular surface epithelium in the rat is regulated by opioid growth factor. Brain Research 1997; 759: 92-102.
14. Zagon IS, Sassani JW, McLaughlin PJ. Re-epithelialization of the rat cornea is accelerated by blockade of opioid receptors. Brain Research 1998; 798: 254-260.
15. Zagon IS, Sassani JW, Wu Y McLaughlin PJ. The autocrine derivation of the opioid growth factor, [Met5]-enkephalin, in ocular surface epithelium. Brain Research 1998; 792: 72-78.
16. Zagon IS, McLaughlin PJ. Production and characterization of polyclonal and monoclonal antibodies to the ξ (zeta) opioid receptor. Brain Research 1993; 630: 295-302.
17. Whitley RD, Gilger BC. Diseases of the canine cornea and sclera. In: Veterinary Ophthalmology, 3rd edn. (ed. Gelatt KN) Lippincott/Williams & Wilkins, Philadelphia, 1999; 635-673.
18. Glaze MB, Gelatt KN. Feline ophthalmology. In: Veterinary Ophthalmology, 3rd edn. (ed. Gelatt KN) Lippincott/Williams & Wilkins, Philadelphia, 1999; 997-1052.
19. Brooks DE. Equine ophthalmology. In: Veterinary Ophthalmology, 3rd edn. (ed. Gelatt KN) Lippincott/Williams & Wilkins, Philadelphia, 1999; 1053-1115.
20. Marfurt CF, Murphy CJ, Florczak JL. Morphology and neurochemistry of canine corneal innervation. Investigative Ophthalmology and Visual Science 2001; 42: 2242-2251.
21. Schultz G, Khaw PT, Oxford K et al. Growth factors and ocular wound healing. Eye 1994; 8: 184-187.
22. Moreira LB, Kasetsuwan N, Sanchez D et al. Toxicity of topical anesthetic agents to human keratocytes in vivo. Journal of Cataract and Refractive Surgery 1999; 25: 975-980.
23. Zagelbaum BM, Totanoski JR, Hochman MA, Hersh PS. Topical lidocaine and proparacaine abuse. American Journal of Emergency Medicine 1994; 12: 96-97.
24. Sun R, Hamilton RC, Gimbel HV. Comparison of 4 topical anesthetic agents for effect and corneal toxicity in rabbits. Journal of Cataract and Refractive Surgery 1999; 25: 1232-1236.
25. Peyman GA, Rahimy MH, Fernandes ML. Effects of morphine on corneal sensitivity and epithelial wound healing: implications for topical ophthalmic analgesia. British Journal of Ophthalmology 1994; 78: 138-141.